Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Abbott Laboratories

3 Attractively Priced Stocks to Buy This Week

The Fed’s continued hawkish monetary policy stance has raised fears of an impending recession. Despite the market pressure, the U.S. GDP saw a positive turnaround in the third quarter of 2022, indicating a resilient economy. Amid this scenario, we think investors should buy fundamentally sound stocks Abbott Laboratories (ABT), Verizon…

StockNews.com

Buying These 2 Stocks Could Be the Best Move You Ever Make

With an albeit decelerating yet solid employment report for October playing into the rationale for slower yet surer hikes by the Fed, the economy seems to be on the brink of a recession. Amid an uncertain economic backdrop, It could be wise to invest in fundamentally strong stocks, Abbott Laboratories…

StockNews.com

5 Stocks to Keep Your Portfolio Safe During a Bear Market

With inflation hovering around the multi-decade high level, further aggressive interest rate hikes seem apparent. Given the weak market outlook, investors could cushion their portfolios by investing in fundamentally sound stocks PepsiCo (PEP), Cisco Systems (CSCO), Abbott Laboratories (ABT), Albertsons Companies (ACI), and Hillenbrand (HI), which have a history of…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022

Upgrades

Benzinga

Is It Too Late to Make Money on ABT Stocks This Fall?

Despite the uncertain macro environment, Abbott (ABT) increased its adjusted EPS guidance for 2022. Wall Street analysts expect it to rally more than 20% in the near term. However, the stock is down 30% year-to-date. So, let's find out if it is the right time to invest in ABT….

StockNews.com

Abbott plans a new $500M baby-formula plant to increase U.S. capacity for the vital product

Abbott Laboratories is building a new infant-formula manufacturing plant after the product shortage of the past year revealed gaps in U.S. production capacity.

Tribune News Service

Check Out What Whales Are Doing With ABT

Someone with a lot of money to spend has taken a bullish stance on Abbott Laboratories (NYSE:ABT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Check out These 3 Stocks if You Want to Get Rich Over Time

Inflation is still running near the highest levels since 1980, despite Fed’s aggressive efforts to tame it. Although economic uncertainties are rising, staying invested and focusing on long-term strategies could be wise. We believe fundamentally solid stocks Microsoft (MSFT), Abbott Laboratories (ABT), and Kroger (KR) could be ideal buys to…

StockNews.com

Baby formula disaster failed to dent Abbott Labs’ ESG score

Several months after the US government began investigating an Abbott Laboratories baby-formula plant for its connection to the deaths of at least two infants, the world’s most influential judge of corporate environmental, social and governance practices upgraded the company.

Tribune News Service

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022

Upgrades

Benzinga

Abbott Laboratories Whale Trades For October 06

A whale with a lot of money to spend has taken a noticeably bullish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories (NYSE:ABT) we detected 10 strange trades.

Benzinga

4 Stocks Investors Could Hold for the Next Decade

Concerns over the Fed’s continued hawkish stance and a potential recession lead to high market volatility. However, no matter what direction the market follows, quality dividend-paying stocks Microsoft (MSFT), Walmart (WMT), Coca-Cola (KO), and Abbott (ABT) could be great investments for the next decade. Read more….

StockNews.com

5 Dividend Stocks to Buy and Hold Forever

Persistent economic turbulence and an uncertain outlook have led investors to prioritize steady income generation from their investments. Hence, fundamentally sound dividend yielders with a solid track record and potential for perpetual growth Merck (MRK), Abbott (ABT), Cigna (CI), Energy Transfer (ET), and Kronos (KRO) could be permanent additions to…

StockNews.com

Latest recalls of formula meant frantic search for family of suburban boy, 5, who needs it to survive

With help from La Rabida Children’s Hospital, Zayne Negoski of Joliet got an alternative tube-feeding formula. But his family and those of other medically needy kids have struggled and often had to pay more after Aug. 10 recall.

Chicago Sun-Times

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Blue-Chip Stocks That'll Help Your Portfolio Survive

Thanks to better-than-expected corporate earnings and the expectation that inflation will cool off, the stock market rebounded from the lows in the year's first half. However, inflation remains elevated, so the Fed is expected to continue its aggressive interest rate hikes. Given this backdrop, investors could cushion their portfolios by…

Benzinga

This Is What Whales Are Betting On Abbott Laboratories

StockNews.com

5 Stocks With the Most Long-Term Growth Potential

While high inflation and GDP decline for two consecutive quarters are raising recession fears, better-than-expected corporate profits and the possibility of a less aggressive rate hike have been restoring investor confidence. Regardless of the uncertainties surrounding the economy and the market, investing in Abbott Laboratories (ABT), Coca-Cola Consolidated (COKE), DLH…

StockNews.com

The Best Stock to Buy for Long-Term Growth

Healthcare company Abbott Labs (ABT) has demonstrated solid growth over the past years. Moreover, the company announced its plans to restart its baby formula business in Michigan. And considering its fundamental strength, we think the stock might be an ideal investment for long-term growth. Read on….

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Is Abbott Labs A "Strong Buy" After Earnings?

Leading healthcare company Abbott Laboratories (ABT) reported strong second-quarter results. And given the company is well-positioned to capitalize on its diverse business and recent FDA approvals, is it wise to buy the stock now? Let’s find out.

Chicago Tribune

Abbott reports strong earnings despite infant formula crisis

Abbott Laboratories reported strong earnings Wednesday, despite spending recent months responding to criticism over problems that led to the shutdown of one of its infant formula-producing plants.

Benzinga

U.S. Stock Futures Edge Higher; Tesla Earnings In Focus

Pre-open movers

StockNews.com

Is Abbott Stock a Buy at $105 as Production in Troubled Plant Resumes?

Leading healthcare company Abbott Laboratories (ABT) reported robust first-quarter results. And the company is well-positioned to benefit from its diversified business. Moreover, as ABT is resuming infant formula production at its Michigan facility, is the stock a good buy at the current price level? Read more to find out….

StockNews.com

This Biotech Stock Looks Like a Prime Growth Play

Diversified healthcare company Abbott (ABT) has demonstrated significant innovations across its segments, and given its dominant market position, the company’s prospects look bright. The stock could be a solid choice as it is well-positioned to survive short-term market fluctuations. Let’s discuss this in detail….

Benzinga

What 6 Analyst Ratings Have To Say About Abbott Laboratories

Abbott Laboratories (NYSE:ABT) has observed the following analyst ratings within the last quarter:

Benzinga

Here's How Much $1000 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today

Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 7.3% on an annualized basis producing an average annual return of 17.14%. Currently, Abbott Laboratories has a market capitalization of $187.96 billion.

1 … 4 5 6 7

People

Kritika SarmahHer

727 stories

Mangeet Kaur BounsMangeet

595 stories

Tyler Pasciak LaRiviere

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.